Does PAROXETINE Cause Ventricular hypertrophy? 17 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Ventricular hypertrophy have been filed in association with PAROXETINE (Paroxetine). This represents 0.1% of all adverse event reports for PAROXETINE.
17
Reports of Ventricular hypertrophy with PAROXETINE
0.1%
of all PAROXETINE reports
1
Deaths
11
Hospitalizations
How Dangerous Is Ventricular hypertrophy From PAROXETINE?
Of the 17 reports, 1 (5.9%) resulted in death, 11 (64.7%) required hospitalization.
Is Ventricular hypertrophy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PAROXETINE. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does PAROXETINE Cause?
Foetal exposure during pregnancy (1,894)
Drug ineffective (1,457)
Toxicity to various agents (1,407)
Drug abuse (1,214)
Anxiety (1,201)
Nausea (1,063)
Suicidal ideation (999)
Drug interaction (991)
Confusional state (975)
Dizziness (937)
What Other Drugs Cause Ventricular hypertrophy?
AMLODIPINE (46)
PREDNISONE (37)
PANTOPRAZOLE (36)
ASPIRIN (32)
VALSARTAN (29)
CLOZAPINE (28)
ACETAMINOPHEN (27)
TIOTROPIUM (24)
ALBUTEROL (21)
ONDANSETRON (21)
Which PAROXETINE Alternatives Have Lower Ventricular hypertrophy Risk?
PAROXETINE vs PAROXETINE\PAROXETINE
PAROXETINE vs PAROXETINE\PAROXETINE ANHYDROUS
PAROXETINE vs PASIREOTIDE
PAROXETINE vs PASIREOTIDE DIASPARTATE
PAROXETINE vs PATIROMER